
Alessandro Foletti
| 2017 – | Octavian, Board Member, Partner, Senior Research Analyst |
| 2013 – 2017 | Bank am Bellevue, Head Research, Senior Industrials Analyst |
| 2010 – 2013 | Self Employed Strategy and M&A Consultant |
| 2007 – 2009 | Bühler Group, Head Corporate Development, Assistant to CEO |
| 2002 – 2007 | Lombard Odier DH, Senior Industrials Analyst |
| 2000 – 2002 | UBS Warburg, Industrials Analyst |
| 1995 – 1999 | PiniSwiss Engineers, PM and Head Quality Management |

Anne-Chantal Risold, PhD
| 2017 – | Octavian, Associate Partner, Senior Research Analyst Financials |
| 2002 – 2015 | Zurich Life Insurance, Head of International Group Risk Solutions (IGRS) actuarial |
| 1996 – 2002 | ETHZ, Scientific collaborator – PhD in Petrography |

Daniel Potashnick
| 2017 – | Octavian, Partner, Research Sales HF & Nordics |
| 2016 – 2017 | Bank am Bellevue, Equity Sales HF/Nordics |
| 2009 – 2016 | JB Capital Markets, Equity Sales HF/Nordics |
| 2007 – 2009 | Execution Ltd, Equity Sales HF/Nordics |
| 2000 – 2007 | Dresdner Kleinwort, Equity Sales / Salestrading HF/Nordics |

Eugi Burgener
| 2024 – | Octavian, Senior Research Sales Switzerland, Luxembourg |
| 2016 – 2024 | Mirabaud Securities, Equity Sales |
| 2004 – 2016 | Helvea Baader, Equity Sales |
| 1997 – 2004 | Sal Oppenheim, Equity Sales |
| 1986 – 1997 | UBS, Analyst |

Frederick Hasslauer
| 2023 – | Octavian, Senior Research Sales UK, USA, Canada |
| 2020 – 2022 | Kieger, Head of Sales & Marketing Europe, Funds / Portfolio Mandates / PE |
| 2004 – 2020 | Bank Vontobel, Executive Director Institutional Sales North America / UK |
| 2001 – 2004 | Credit Agricole Indosuez Cheuvreux, Senior Equity Research Sales |
| 1993 – 2001 | Bank Sal. Oppenheim, Institutional Sales / Analyst |
| 1987 – 1993 | Schweizerische Volksbank, Analyst and Junior Fund Manager for Asia / Europe |

Joris Zimmermann
| 2024 – | Octavian, Research Analyst Healthcare |
| 2022 – 2023 | Bayer AG, Director Commercial Assessment, Global BD&L Pharma |
| 2020 – 2022 | Global Marketing Manager |
| 2017 – 2020 | Bayer (Schweiz) AG, Head / Lead Marketing Cardiovascular Business |
| 2013 – 2017 | Product Manager |
| 2009 – 2012 | Nycomed Pharma AG, Medical Marketing Manager, Specialized Hospital Products |
| 2011 | EPFL Lausanne, CAS Management of Biotech, Medtech & Pharma Ventures |
| 2003– 2008 | ETH Zurich, MSc & BSc Human Movement Sciences |

Karol Brodzinski
| 2025 – | Octavian, Research Analyst |
| 2023 – 2024 | Deloitte, Assistant Manager, CF Advisory |
| 2021 – 2022 | Green Eight Capital, Investment Analyst |
| 2019 – 2021 | Deloitte, Senior Consultant Valuation and Financial Modeling |
| 2016 – 2018 | Erste Group, Equity Research Analyst |
| 2014 – 2016 | Deutsche Bank, Equity Research Analyst |

Laura Bucher
| 2021 – | Octavian, Research Analyst |
| 2015 – 2017 | Lygia Mattos, Business Officer |
| 2013 – 2014 | Ibmex, Internship, Project Manager, Junior Consultant |

Laura Pfeifer-Rossi
| 2017 – | Octavian, Partner, Senior Research Analyst |
| 2015 – 2017 | Bank am Bellevue, Senior Healthcare Research Analyst, Deputy Head Research |
| 2014 | Vifor Pharma, Business Development |
| 2011 – 2014 | Sophora Advisors, Consultant Healthcare |
| 2000 – 2009 | Bellevue Asset Management, Member of BoD BB Medtech, Buyside Analyst & PM, Head of Mgmt Team BB Medtech |

Lothar Lubinetzki
| 2018 – | Octavian, Senior Research Analyst Industrials |
| 2001 – 2016 | MainFirst Group, Senior Equity Analyst |
| 2000 – 2001 | Metzler, Senior Equity Analyst |
| 1994 – 2000 | Enskilda Securities, Senior Equity Analyst |
| 1991 – 1994 | HSBC Trinkaus & Burkhardt, Research Analyst |

Marius Zuberbuehler
| 2017 – | Octavian, Vice Chairman, Partner, Corporate Finance |
| 2013 – 2017 | Bank am Bellevue, Managing Director Corporate Finance |
| 2007 – 2012 | Deutsche Bank (London, Zurich), Corporate Finance, Head ECM Switzerland |
| 2001 – 2007 | Merrill Lynch (London), VP Corporate Finance |
| 1997 – 2001 | Roland Berger Strategy Consultants, Senior Consultant |
| 1991 – 1993 | UBS, Analyst Corporate Banking |

Martin Schuler
| 2017 – | Octavian, Partner Research Sales CH & Sales Trading |
| 2009 – 2017 | Bank am Bellevue, Head of Trading & Salestrading |
| 2007 – 2009 | Morgan Stanley (Zurich), Salestrading Equities & Equity-linked |
| 2006 – 2007 | Bank Leu, Treasurer (FX, Metals, MM) |
| 1999 – 2006 | Merrill Lynch CM (Zurich), Head Global Salestrading |
| 1997 – 1999 | Crédit Lyonnais Securities, Pan Euro Equity Sales |
| 1986 – 1997 | Credit Suisse, Global Option Book, FX, MM & Liquidity steering |

Michael Nawrath
| 2021 – | Octavian, Senior Advisor Healthcare Research |
| 2007 – 2021 | ZKB, Senior Sell-side Analyst Pharma / Biotech |
| 2000 – 2006 | CSAM, Fundmanager Global Biotech |
| 1994 – 2000 | University of Zurich, Postdoc Medical Virology |
| 1990 – 1994 | Freie University of Berlin, Physician (Minimal invasive Surgeon in Orthopedics) |

Nejc Lavric
| 2022 – | Octavian, Senior Advisor Healthcare Research |
| 2021 – 2022 | Ernst and Young, Financial Services – Risk (Working Student) |
| 2018 – 2020 | Education First / Hult IBS, Recruiter and Business Developer |
| 2016 | Novartis / Lek Pharmaceuticals, Buiness Planning (Intern) |
| 2015 | Ilirika Brokerage, Brokerage Clerk (Intern) |

René Saner
| 2017 – | Octavian, Partner, Research Sales UK/US/LatAm |
| 2006 – 2017 | Bank am Bellevue, Head Equity Sales |
| 2000 – 2006 | Bank am Bellevue (Swissfirst Bank), WM & UHNWI Advisory |
| 1996 – 2000 | LGT Bank (STG AM), PM European Equities |
| 1990 – 1996 | Ilirika Brokerage, Brokerage Clerk (Intern) |
| 1987 – 1990 | Credit Suisse (Bank Leu), Bank apprenticeship |

Sandra Dietschy, PhD
| 2022 – | Octavian, Associate Partner, Senior Research Analyst Healthcare |
| 2020 – 2022 | Accenture, Senior Principal Life Sciences |
| 2015 – 2019 | Molecular Partners, Associate Director Business & Pipeline Strategy |
| 2008 – 2015 | Bank am Bellevue, Equity Research Analyst Healthcare |
| 2004 – 2007 | University of Zurich, PhD in Neuroscience |

Serge Monnerat
| 2017 – | Octavian, Chairman, Partner, Research Sales |
| 2010 – 2017 | Bank am Bellevue, CEO |
| 2001 – 2010 | Bank am Bellevue, Head Research |
| 1992 – 2000 | BZ Bank, Research/Equity Sales |

Verena Münch
| 2020 – | Octavian, Associate Partner, Senior Research Sales CH & Germany |
| 2006 – 2020 | Bank Vontobel, Swiss Equities Specialist Sales, ED |
| 2005 – 2006 | LODH, Swiss Equities Specialist Sales, VP |
| 2001 – 2006 | Deutsche Bank, Swiss Equities Specialist Sales, Associate |
| 2000 | MEAG Securities Management, Risk Management (Intern) |
| 1997 | Framatome, Finance (Intern) |
| 1996 | HypoVereinsbank, Strategic Investment Mgmt. (Intern) |

